In AD, which is a neurodegenerative disorder characterized by the progressive cognitive decline and by accumulation of insoluble aggregates of two proteins in the brain, amyloid-β (Aβ) and the microtubule-associated protein tau, Aβ levels and tau aggregation are impacted by altered sumoylation (Lee et al., 2013). Here, MAPT is linked to Alzheimer disease.